Financial Performance & Strategy - Elanco reported revenue of $4439 billion in 2024[10] - Adjusted EPS was $091 in 2024[10] - Adjusted EBITDA reached $910 million in 2024[10] - The company expects $660-$740 million in incremental revenue from innovation by 2025[19, 33, 41] - Elanco anticipates revenue growth of 4%-6% in 2025[49] Portfolio & Market - Pet health accounts for 50% of Elanco's revenue[47] - Farm animal also accounts for 50% of Elanco's revenue[47] - 53% of revenue comes from outside the U S[10] - The global animal health pharmaceutical industry is valued at approximately $41 billion, with pet health at $16 billion and farm animal at $25 billion[19] Debt Reduction - Elanco reduced gross debt by $148 billion in 2024[76]